Overview
Francesca Drago practices practicing medicine in Messina, Italy.
Their clinical expertise encompasses Glutaric Acidemia Type 2, Rhabdomyolysis, and Venous Insufficiency.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Francesca A. Drago
Is Francesca A. Drago a top-rated expert for Glutaric Acidemia Type 2?
MediFind is an objective health platform that identifies experts based on real-world data. Francesca A. Drago is classified as an Experienced expert for Glutaric Acidemia Type 2, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Francesca A. Drago participate in research or clinical trials?
Yes. Francesca A. Drago has published 11 articles and abstracts on conditions like Glutaric Acidemia Type 2. You can view a list of Francesca A. Drago's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Glutaric Acidemia Type 2Drago isExperienced. Learn about Glutaric Acidemia Type 2.
- RhabdomyolysisDrago isExperienced. Learn about Rhabdomyolysis.
- Venous InsufficiencyDrago isExperienced. Learn about Venous Insufficiency.